title: Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis.
authors.affiliation: Department of medicine and aging science, Dermatologic Clinic.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Capo
authors.affiliation: Department of experimental and clinical sciences, Biostatistics Laboratory.
authors.forename: Marta
authors.initials: M
authors.lastname: Di Nicola
authors.affiliation: Department of experimental and clinical science, Dermatologic clinic.
authors.forename: Matteo
authors.initials: M
authors.lastname: Auriemma
authors.affiliation: Department of clinical medicine and surgery, Dermatologic clinic, University of Padova, Padova, Italy.
authors.forename: Stefano
authors.initials: S
authors.lastname: Piaserico
authors.affiliation: Department of medicine and health sciences, University of Molise, Cambobasso, Italy.
authors.forename: Chiara
authors.initials: C
authors.lastname: Cuccurullo
authors.affiliation: Department of medicine and aging science, Center for excellence on aging (CeSI), University G.d'Annunzio, Chieti, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Santilli
authors.affiliation: Department of medicine and aging science, Center for excellence on aging (CeSI), University G.d'Annunzio, Chieti, Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Davi
authors.affiliation: Department of medicine and aging science, Dermatologic Clinic.
authors.forename: Paolo
authors.initials: P
authors.lastname: Amerio
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000097:blood* / Q000188:drug therapy*; D001691:Biological Therapy; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D000069285:Infliximab; D063847:Mean Platelet Volume; D008875:Middle Aged; D011565:Psoriasis / Q000097:blood* / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab; D000068800:Etanercept